BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27532517)

  • 1. Cilostazol Prevents Atrial Structural Remodeling through the MEK/ERK Pathway in a Canine Model of Atrial Tachycardia.
    Zhao Z; Wang Y; Chen Y; Wang X; Li J; Yuan M; Liu T; Li G
    Cardiology; 2016; 135(4):240-248. PubMed ID: 27532517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cilostazol ameliorates atrial ionic remodeling in long-term rapid atrial pacing dogs.
    Zhao Z; Li W; Wang X; Chen Y; Li J; Yang W; Cheng L; Liu E; Liu T; Li G
    Anatol J Cardiol; 2015; 15(12):963-9. PubMed ID: 25880049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of experimental atrial fibrillation in a canine model of rapid atrial pacing by the phosphodiesterase 3 inhibitor cilostazol.
    Zhao Z; Li R; Wang X; Li J; Xu X; Liu T; Liu E; Li G
    J Electrocardiol; 2020; 60():151-158. PubMed ID: 32371198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of irbesartan on development of atrial fibrosis and atrial fibrillation in a canine atrial tachycardia model with left ventricular dysfunction, association with p53.
    Kataoka N; Nishida K; Kinoshita K; Sakamoto T; Nakatani Y; Tsujino Y; Mizumaki K; Inoue H; Kinugawa K
    Heart Vessels; 2016 Dec; 31(12):2053-2060. PubMed ID: 27236656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of atrial remodeling by aliskiren via affecting oxidative stress, inflammation and PI3K/Akt signaling pathway.
    Zhao Z; Li R; Wang X; Li J; Yuan M; Liu E; Liu T; Li G
    Cardiovasc Drugs Ther; 2021 Jun; 35(3):587-598. PubMed ID: 32462265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aliskiren protecting atrial structural remodeling from rapid atrial pacing in a canine model.
    Zhao Z; Chen Y; Li W; Wang X; Li J; Yang W; Cheng L; Liu T; Liu E; Li G
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):863-71. PubMed ID: 27118660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of atrial natriuretic peptide in the effects of Angiotensin-(1-7) in a chronic atrial tachycardia canine model.
    Zhao J; Liu T; Liu E; Li G; Qi L; Li J
    J Renin Angiotensin Aldosterone Syst; 2016; 17(1):1470320315627409. PubMed ID: 27009283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enalapril, irbesartan, and angiotensin-(1-7) prevent atrial tachycardia-induced ionic remodeling.
    Liu E; Xu Z; Li J; Yang S; Yang W; Li G
    Int J Cardiol; 2011 Feb; 146(3):364-70. PubMed ID: 19732978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme-2 overexpression improves atrial remodeling and function in a canine model of atrial fibrillation.
    Zhou T; Wang Z; Fan J; Chen S; Tan Z; Yang H; Yin Y
    J Am Heart Assoc; 2015 Mar; 4(3):e001530. PubMed ID: 25792125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-(1-7) prevents atrial fibrosis and atrial fibrillation in long-term atrial tachycardia dogs.
    Liu E; Yang S; Xu Z; Li J; Yang W; Li G
    Regul Pept; 2010 Jun; 162(1-3):73-8. PubMed ID: 20074590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of cilazapril and valsartan on the mRNA and protein expressions of atrial calpains and atrial structural remodeling in atrial fibrillation dogs.
    Li Y; Li WM; Gong YT; Li BX; Liu W; Han W; Dong D; Sheng L; Xue JY; Zhang L; Chu S; Yang BF
    Basic Res Cardiol; 2007 May; 102(3):245-56. PubMed ID: 17268887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the angiotensin-(1-7)/Mas/PI3K/Akt/nitric oxide axis and the possible role of atrial natriuretic peptide in an acute atrial tachycardia canine model.
    Zhao J; Liu E; Li G; Qi L; Li J; Yang W
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1069-77. PubMed ID: 25143331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irbesartan prevents sodium channel remodeling in a canine model of atrial fibrillation.
    Wang X; Li G
    J Renin Angiotensin Aldosterone Syst; 2018; 19(1):1470320318755269. PubMed ID: 29378480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of aliskiren on atrial ionic remodeling in a canine model of rapid atrial pacing.
    Zhao Z; Wang X; Li J; Yang W; Cheng L; Chen Y; Liu T; Liu E; Chen K; Li G
    Cardiovasc Drugs Ther; 2014 Apr; 28(2):137-43. PubMed ID: 24488001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tranilast prevents atrial remodeling and development of atrial fibrillation in a canine model of atrial tachycardia and left ventricular dysfunction.
    Nakatani Y; Nishida K; Sakabe M; Kataoka N; Sakamoto T; Yamaguchi Y; Iwamoto J; Mizumaki K; Fujiki A; Inoue H
    J Am Coll Cardiol; 2013 Feb; 61(5):582-8. PubMed ID: 23273396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-(1-7) prevent atrial tachycardia induced sodium channel remodeling.
    Wang X; Li G
    Pacing Clin Electrophysiol; 2014 Oct; 37(10):1349-56. PubMed ID: 24861429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Qiliqiangxin attenuates atrial structural remodeling in prolonged pacing-induced atrial fibrillation in rabbits.
    Tingting H; Guangzhong L; Yanxiang Z; DongDong Y; Li S; Li W
    Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):585-592. PubMed ID: 30627756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial overexpression of angiotensin-converting enzyme 2 improves the canine rapid atrial pacing-induced structural and electrical remodeling. Fan, ACE2 improves atrial substrate remodeling.
    Fan J; Zou L; Cui K; Woo K; Du H; Chen S; Ling Z; Zhang Q; Zhang B; Lan X; Su L; Zrenner B; Yin Y
    Basic Res Cardiol; 2015; 110(4):45. PubMed ID: 26143546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of the Rho/ROCK Pathway in Ang II and TGF-β1-Induced Atrial Remodeling.
    Liu LJ; Yao FJ; Lu GH; Xu CG; Xu Z; Tang K; Cheng YJ; Gao XR; Wu SH
    PLoS One; 2016; 11(9):e0161625. PubMed ID: 27611832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.
    Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K
    Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.